Rnz: Morning Report
Ground breaking clinical trial for blood cancer continues
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:03:32
- Mas informaciones
Informações:
Sinopsis
Sixty patients with the rare non-Hodgkin Lymphoma blood cancer, will be given CAR-T Cell therapy which reprogrammes their immune cells to recognise and kill cancer cells. Cancer patient David Down spoke to Ingrid Hipkiss.
